Related Experiment Video

Updated: May 24, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis

Dong Hu1, Zhuan Zhou, Nancy E Davidson

  • 1Department of Cell Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

The Journal of Biological Chemistry
|March 6, 2012
PubMed

Insights

Krüppel-like factor 4 (KLF4) drives estrogen signaling in breast cancer by accumulating when pVHL protein decreases. This KLF4 accumulation promotes estrogen-induced cell growth, a mechanism observed in breast cancer tissues.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Endocrinology

Background:

  • Krüppel-like factor 4 (KLF4) is a transcription factor with dual roles in cancer, acting as a tumor suppressor or oncoprotein depending on the context.
  • The precise mechanisms underlying KLF4's opposing roles in carcinogenesis, particularly in breast cancer, remain largely undetermined.

Purpose of the Study:

  • To elucidate the role of KLF4 in mediating estrogen signaling in breast cancer development.
  • To identify the regulatory mechanisms governing KLF4 stability and its link to estrogen-induced cellular processes.

Main Methods:

  • Investigated KLF4 turnover and its regulation by estrogen signaling in breast cancer cells.
  • Identified the Von Hippel-Lindau protein (pVHL) as a key regulator of KLF4 degradation.
  • Utilized immunohistochemical staining to analyze KLF4 and pVHL levels in human breast cancer tissues.

Main Results:

  • Estrogen signaling leads to the down-regulation of pVHL, which in turn facilitates KLF4 accumulation.
  • Elevated KLF4 levels, driven by estrogen-induced pVHL suppression, promote estrogen-induced transactivation and cell proliferation.
  • Reduced pVHL and accumulated KLF4 were observed in clinical breast cancer samples, correlating with the proposed mechanism.

Conclusions:

  • KLF4 acts as a mediator of estrogen signaling in breast cancer formation.
  • Estrogen-induced suppression of pVHL is a critical step leading to KLF4 accumulation and subsequent mitogenic effects.
  • Targeting the pVHL-KLF4 axis may offer a novel therapeutic strategy for estrogen-driven breast cancers.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...